A recent House Energy & Commerce Health Subcommittee hearing brought bipartisan attention to the high cost of hospital price opacity. Lawmakers on both sides of the aisle voiced frustration that patients still can't easily see healthcare prices before receiving care — with more than 75% of hospitals still not fully compliant with existing transparency rules.
Key takeaways:
- Employers and private insurers pay hospitals an average of 254% of Medicare rates for the same services, limiting employers' ability to negotiate fair prices.
- Consolidation and private equity ownership were flagged as drivers of rising costs without corresponding gains in care quality.
- The 340B drug pricing program was singled out as especially opaque, with employers largely unable to see how much they lose to it in reduced rebates.
- Witnesses urged Congress to pair transparency rules with site-neutral payment policies and limits on facility fees.
The takeaway for employers: bipartisan momentum is building, but real relief will require pairing transparency with stronger enforcement and structural reforms.
Read more:on Employers for Hospital Accountability